haematology
People whose work centres on haematology. 20 records carry it: 20 people.
Related tags
20 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Benjamin Kasenda Senior Physician, Medical Oncology and Haematology (Tumour Centre) · University Hospital Basel / Tumour Centre Basel haematologist-oncologist who co-led phase 2 trials of high-dose chemotherapy and autologous transplant in primary CNS lymphoma. | Primary CNS lymphoma | none | clinician-scientist, lymphoma | ||
Benjamin Kile Executive Director · Garvan Institute of Medical Research / Kinghorn Cancer Centre Blood cell molecular biologist who has led Sydney's Garvan Institute of Medical Research since 2023, sharpening its focus on genomics, immunology and cancer. | none | none | leadership, clinician-scientist, genomics | ||
Brian Huntly President Elect · European Hematology Association Cambridge haematologist and EHA President Elect whose laboratory studies how epigenetic regulators drive leukaemia and how they can be targeted. | Acute myeloid leukaemia | none | leadership, clinician-scientist, leukaemia | ||
Chris Hillis Vice President, Oncology and Site Executive, Juravinski Hospital and Cancer Centre, Hamilton Health Sciences · Juravinski Cancer Centre / Escarpment Cancer Research Institute Blood cancer specialist who leads the Juravinski Cancer Centre, one of Ontario's largest integrated cancer programmes, as Vice President of Oncology. | Chronic lymphocytic leukaemia | none | leadership, clinician-scientist | ||
Christian Brandts Director, UCT Frankfurt (Geschäftsführender Direktor) · University Cancer Center Frankfurt (UCT) Haematologist-oncologist who is Managing Director of the University Cancer Center Frankfurt. | Acute myeloid leukaemia | none | leadership, clinician-scientist, precision oncology | ||
Christiane Pott President (Praesidentin) of the German Lymphoma Alliance · German Lymphoma Alliance Kiel professor of medicine who serves as President of the German Lymphoma Alliance, the umbrella body for German lymphoma study groups, alongside co-president Georg Lenz. | none | none | leadership, clinician-scientist, cooperative-group | ||
Franck Morschhauser President · LYSA (The Lymphoma Study Association) Lille haematologist and President of LYSA, the French-Belgian lymphoma cooperative group, who led the RELEVANCE trial of chemotherapy-free therapy in follicular lymphoma. | Follicular lymphoma, Diffuse large B-cell lymphoma | none | leadership, clinician-scientist, lymphoma | ||
Hubert Serve Director, Department of Internal Medicine 2 (Hematology/Oncology) · University Cancer Center Frankfurt (UCT) Leukaemia specialist heading haematology and oncology at University Hospital Frankfurt and co-author of the pivotal RATIFY midostaurin trial. | Acute myeloid leukaemia | none | leadership, clinician-scientist, leukaemia | ||
Joaquín Martínez-López Head of the Haematology Department · Hospital Universitario 12 de Octubre Haematologist who heads the Haematology Department at Hospital 12 de Octubre and the joint H12O-CNIO haematological malignancies unit, known for myeloma and MRD research. | Multiple myeloma, Myeloproliferative neoplasms | none | clinician-scientist, multiple myeloma | ||
Jürgen Kuball Daily Board member, Strategic Program Cancer · UMC Utrecht Cancer Center Utrecht haematologist and immunotherapy researcher on the daily board of UMC Utrecht's cancer programme, known for gamma-delta T cell receptor-engineered cell therapies. | Acute myeloid leukaemia, Multiple myeloma | none | leadership, clinician-scientist, immunotherapy | ||
Konstanze Döhner President · European Hematology Association Ulm haematologist and President of the European Hematology Association, a leading figure in the molecular genetics and risk classification of acute myeloid leukaemia. | Acute myeloid leukaemia | none | leadership, clinician-scientist, leukaemia | ||
Marc H.G.P. Raaijmakers Vice Chair · HOVON Erasmus MC haematologist and HOVON Vice Chair known for research on the bone marrow microenvironment in MDS. | Myelodysplastic syndromes / neoplasms, Acute myeloid leukaemia | none | leadership, clinician-scientist, MDS | ||
Martin Bornhäuser Managing Director (Geschäftsführender Direktor); Director, Medizinische Klinik und Poliklinik I · NCT/UCC Dresden, University Hospital Carl Gustav Carus Dresden haematologist and transplant physician who co-directs the NCT/UCC Dresden cancer centre and leads AML transplant trials. | Acute myeloid leukaemia, Multiple myeloma | none | leadership, clinician-scientist, leukaemia | ||
Nicolaas P.M. Schaap Chair · HOVON Radboudumc haematologist who chairs HOVON, the Dutch-Belgian haemato-oncology cooperative group. | Acute myeloid leukaemia, Multiple myeloma | none | leadership, clinician-scientist, stem cell transplantation | ||
Norbert Vey Directeur Général (Director General) of Institut Paoli-Calmettes · Institut Paoli-Calmettes Haematologist specialising in leukaemia who has directed Institut Paoli-Calmettes, the Marseille comprehensive cancer centre, since May 2022. | Acute myeloid leukaemia, Acute lymphoblastic leukaemia | none | leadership, clinician-scientist | ||
R. Angelo de Claro Director, Oncology Center of Excellence, US Food and Drug Administration · FDA Oncology Center of Excellence Haematologist-oncologist who has directed the FDA's Oncology Center of Excellence since March 2025 and previously led its global clinical sciences programme, including Project Orbis. | none | none | leadership, clinician-scientist, regulatory | ||
Robert Negrin President of the American Society of Hematology (2026) · American Society of Hematology Stanford transplant physician and cellular immunologist who is President of the American Society of Hematology for 2026. | none | none | leadership, clinician-scientist, society | ||
Sascha Dietrich Deputy Medical Director · University Hospital Düsseldorf / CIO Düsseldorf Haematologist-oncologist and Deputy Medical Director at University Hospital Düsseldorf, known for drug-response profiling in lymphoma and leukaemia. | Chronic lymphocytic leukaemia, Hairy cell leukaemia, Diffuse large B-cell lymphoma | none | leadership, clinician-scientist, lymphoma | ||
Thomas Kindler Director · University Cancer Center Mainz (UCT Mainz) / Universitätsmedizin Mainz Haematologist-oncologist who directs the University Cancer Center Mainz at Universitätsmedizin Mainz. | Acute myeloid leukaemia | none | leadership, clinician-scientist, leukaemia | ||
Tim Somervaille Senior Group Leader · Cancer Research UK Manchester Institute Haematologist and Senior Group Leader at CRUK Manchester Institute studying the transcriptional drivers of acute myeloid leukaemia. | Acute myeloid leukaemia | none | clinician-scientist, leukaemia |